East Oregonian

Ultima Genomics increases output by over 50% and lowers sequencing costs by a further 20% with the introduction of UG 100 Solaris™

FREMONT, Calif., Feb. 24, 2025 /PRNewswire/ — Ultima Genomics, Inc., a developer of an ultra-high-throughput sequencing architecture, today announced the commercial launch of UG 100 Solaris at the ...
The Daily Astorian

Ultima Genomics expands global access to high-quality, low-cost DNA sequencing on the UG 100™ sequencing platform through partnerships with multiple premier genomic services ...

FREMONT, Calif., Feb. 25, 2025 /PRNewswire/ — Ultima Genomics, Inc., developer of the UG100™ next-generation sequencing (NGS) platform, today announced expanded global access to high-quality, low-cost ...
Seeking Alpha

PacBio Announces Major Advances for Revio and Vega to Lower Genome Cost and Expand Multiomic Capabilities

MENLO PARK, Calif., Oct. 14, 2025 (GLOBE NEWSWIRE) -- PacBio (PACB), developer of the world's most advanced sequencing technologies, today announced innovations to its Revio and Vega platforms ...
Medical News Today

Single blood sample could soon screen for several cancers, study suggests

A new study suggests that a single blood sample could soon detect multiple cancers, including liver, stomach, and lung cancer ...
BioTechniques

How long-read sequencing is scaling beyond the specialist lab

Explore how advances in accuracy, throughput and cost are making long-read sequencing more accessible at scale.
news.ucsc

Long read sequencing reveals more genetic information while cutting time and cost of rare disease diagnoses

One in every 10 people worldwide is impacted by a rare genetic disease but about 50% of them remain undiagnosed despite rapid increases in genetic technology and testing. Even when a person does have ...